Volume 123; Issue 1

Main
Gynecologic Oncology
Volume 123; Issue 1

Gynecologic Oncology

Volume 123; Issue 1

1

The use of an “old-fashioned method” to assess the clinical and economic impact of a HPV vaccination program

Francesco Saverio Mennini, Alessandro Capone, Giampiero Favato

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 62 KB

english, 2011

2

Is There a Real Standard For Stage IVa Cervical Cancer?

Filippo Bellati, Maria Luisa Gasparri, Pierluigi Benedetti Panici

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 208 KB

english, 2011

3

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas

Alison M. Karst, Keren Levanon, Sekhar Duraisamy, Joyce F. Liu, Michelle S. Hirsch, Jonathan L. Hecht, Ronny Drapkin

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 2.16 MB

english, 2011

4

SCOTCERV: A phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer

R.P. Symonds, S.E. Davidson, S. Chan, N.S. Reed, T. McMahon, D. Rai, S. Harden, J. Paul

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 158 KB

english, 2011

5

Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group

K. Baumann, J. Pfisterer, P. Wimberger, N. Burchardi, C. Kurzeder, A. du Bois, S. Loibl, J. Sehouli, J. Huober, B. Schmalfeldt, I. Vergote, H.J. Lück, U. Wagner

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 255 KB

english, 2011

6

Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40 years of age and younger

K.K. Shih, K. Garg, D.A. Levine, N.D. Kauff, N.R. Abu-Rustum, R.A. Soslow, R.R. Barakat

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 412 KB

english, 2011

7

The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC)

Sonia Dutta, Feng-qiang Wang, Hai-shan Wu, Thayer J. Mukherjee, David A. Fishman

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 1.05 MB

english, 2011

8

Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus

Daniel T. Rein, Anne Volkmer, Ines M. Beyer, David T. Curiel, Wolfgang Janni, Anca Dragoi, Alexandra P. Hess, Nicolai Maass, Stephan E. Baldus, Gerd Bauerschmitz, Martina Breidenbach

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 960 KB

english, 2011

9

Accuracy of Diffusion-Weighted Echo-Planar MR Imaging and ADC Mapping in the evaluation of residual Cervical Carcinoma after radiation therapy

Antonin Levy, Caroline Caramella, Cyrus Chargari, Aicha Medjhoul, Annie Rey, Elise Zareski, Bérénice Boulet, François Bidault, Clarisse Dromain, Corinne Balleyguier

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 739 KB

english, 2011

10

Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer

Xiong Ying, Liang Li-zhi, Cao Li-ping, Zheng Min, Liu Ji-hong

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 280 KB

english, 2011

11

Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies

Akila Subramaniam, Kenneth H. Kim, Shannon A. Bryant, Kristopher J. Kimball, Warner K. Huh, J. Michael Straughn, Jacob M. Estes, Ronald D. Alvarez

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 289 KB

english, 2011

12

Leuprolide acetate depot plus high-dose raloxifene hydrochloride before and after surgery for recurrent vaginal aggressive angiomyxoma: A case report

Stefano Palomba, Rosamaria Oppedisano, Gianluca Annunziata, Fulvio Zullo, Andrea Amorosi

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 205 KB

english, 2011

13

Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix

W.F. van der Meide, S. Snellenberg, C.J.L.M. Meijer, A. Baalbergen, T.J.M. Helmerhorst, W.B. van der Sluis, P.J.F. Snijders, R.D.M. Steenbergen

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 708 KB

english, 2011

14

The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma

Erin R. King, Zhifei Zu, Yvonne T.M. Tsang, Michael T. Deavers, Anais Malpica, Samuel C. Mok, David M. Gershenson, Kwong-Kwok Wong

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 899 KB

english, 2011

15

The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data

Peter Svenssen Munksgaard, Jan Blaakaer

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 181 KB

english, 2011

16

The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer

Jamie N. Bakkum-Gamez, Andrea Mariani, Sean C. Dowdy, Amy L. Weaver, Michaela E. McGree, William A. Cliby, Bobbie S. Gostout, C. Robert Stanhope, Timothy O. Wilson, Karl C. Podratz

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 202 KB

english, 2011

17

Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study

Lubomir Bodnar, Maria Górnas, Cezary Szczylik

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 148 KB

english, 2011

18

Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: Success, morbidity and survival

James Fanning, Emmanuel Yacoub, Rod Hojat

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 192 KB

english, 2011

19

Oncolytic virotherapy of breast cancer

Andreas D. Hartkopf, Tanja Fehm, Diethelm Wallwiener, Ulrich M. Lauer

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 683 KB

english, 2011

20

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: A Gynecologic Oncology Group study

Kian Behbakht, Michael W. Sill, Kathleen M. Darcy, Stephen C. Rubin, Robert S. Mannel, Steven Waggoner, Russell J. Schilder, Kathy Q. Cai, Andrew K. Godwin, R. Katherine Alpaugh

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 763 KB

english, 2011

21

High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas

Alexandra Giatromanolaki, Michael I. Koukourakis, Anastasios Koutsopoulos, Pelagia Chloropoulou, Vasileios Liberis, Efthimios Sivridis

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 748 KB

english, 2011

22

Early adenocarcinoma of the cervix: Is radical vaginal trachelectomy safe?

L. Helpman, D. Grisaru, A. Covens

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 237 KB

english, 2011

23

Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma

Patricia A. Convery, Leigh A. Cantrell, Nicola Di Santo, Gloria Broadwater, Susan C. Modesitt, Angeles Alvarez Secord, Laura J. Havrilesky

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 251 KB

english, 2011

24

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer

Keiichiro Nakamura, Atsushi Hongo, Junichi Kodama, Yuji Hiramatsu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 468 KB

english, 2011

25

Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment

Kate E. Oliver, Lindsey R. Enewold, Kangmin Zhu, Thomas P. Conrads, G. Scott Rose, G. Larry Maxwell, John H. Farley

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 140 KB

english, 2011

26

Frozen section diagnoses of 578 ovarian tumors made by pathologists with and without expertise on gynecologic pathology

Ozgur Bige, Ahmet Demir, Ugur Saygili, Funda Gode, Turhan Uslu, Meral Koyuncuoglu

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 139 KB

english, 2011

27

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: A single institution experience

A. Bamias, A. Karadimou, N. Soupos, M. Sotiropoulou, F. Zagouri, D. Haidopoulos, N. Thomakos, A. Rodolakis, A. Antsaklis, M.A. Dimopoulos

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 413 KB

english, 2011

28

Commentary on “Is there a real standard for stage IVa cervical cancer?”

Peter G. Rose, Shamshad Ali

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 47 KB

english, 2011

29

Hysterectomy for uterine adenocarcinoma in the elderly: Tumor characteristics, and long-term outcome

Omar H. Gayar, Jared R. Robbins, Keyur Parikh, Mei Lu, Thomas Buekers, Adnan Munkarah, Mohamed A. Elshaikh

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 467 KB

english, 2011

30

Ovarian immature teratoma: Treatment and outcome in a single institutional cohort

Danielle Vicus, Mario E. Beiner, Blaise Clarke, Shany Klachook, Lisa W. Le, Stephane Laframboise, Helen Mackay

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 215 KB

english, 2011

31

Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy — An observational study

S. Zahra, J.A.M. Anderson, D. Stirling, C.A. Ludlam

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 164 KB

english, 2011

32

Low TWEAK expression is correlated to the progression of squamous cervical carcinoma

Heng Zou, Dengfeng Wang, Xiaoling Gan, Long Jiang, Chen Chen, Lina Hu, Yi Zhang

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 717 KB

english, 2011

33

Response to: "The use of an “old-fashioned method” to assess the clinical and economic impact of a HPV vaccination program"

S. Capri, R. Gasparini, D. Panatto, N. Demarteau

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 51 KB

english, 2011

34

The evolving pathogenesis model of high-grade pelvic serous carcinoma

Joyce N. Barlin, Douglas A. Levine

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 107 KB

english, 2011

35

Gynecologic Oncology Group (GOG) Report

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 103 KB

english, 2011

36

Editorial Board

Journal:

Gynecologic Oncology

Year:

2011

Language:

english

File:

PDF, 29 KB

english, 2011